Related Experiment Videos
Primary biliary cirrhosis in an elderly man with normal liver tests
1Department of Pathology and Laboratory Medicine, The Brody School of Medicine, East Carolina University, Greenville, NC 27834, USA.
Southern Medical Journal
|December 18, 2009
Summary
Primary biliary cirrhosis (PBC), a rare cholestatic liver disease, can affect men. This case highlights a 78-year-old male diagnosed with early-stage PBC via liver biopsy and antimitochondrial antibody testing.
Area of Science:
- Hepatology
- Autoimmune Diseases
- Cholestatic Liver Disease
Background:
- Primary biliary cirrhosis (PBC) is a chronic autoimmune liver disease characterized by cholestasis.
- PBC predominantly affects middle-aged women, with a male-to-female ratio of approximately 1:10.
Observation:
- This report details a rare case of a 78-year-old male patient presenting with pruritus.
- The patient's clinical presentation prompted further investigation into potential liver pathology.
Findings:
- Diagnostic investigations, including liver biopsy and antimitochondrial antibody (AMA) serology, confirmed early-stage PBC.
- The findings underscore that PBC is not exclusively a disease of women.
Implications:
- This case expands the known demographic profile of primary biliary cirrhosis.
- It emphasizes the importance of considering PBC in older men presenting with cholestatic symptoms like pruritus.
- Early diagnosis through serological and histological markers is crucial for timely management.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment: